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Glycan epitopes of cellular glycoconjugates act as ver-
satile biochemical signals (sugar coding). Here, we test
the hypothesis that the common N-glycan modifications
by core fucosylation and introduction of the bisecting N-
acetylglucosamine moiety have long-range effects with
functional consequences. Molecular dynamics simula-
tions indicate a shift in conformational equilibria between
linear extension or backfolding of the glycan antennae
upon substitution. We also present a new fingerprint-like
mode of presentation for this multi-parameter system.
In order to delineate definite structure-function relation-
ships, we strategically combined chemoenzymatic syn-
thesis with bioassaying cell binding and the distribution
of radioiodinated neoglycoproteins in vivo. Of clinical rel-
evance, tailoring the core region affects serum clearance
markedly, e.g., prolonging circulation time for the neogly-
coprotein presenting the N-glycan with both substitu-
tions. a2,3-Sialylation is another means toward this end,
similarly seen for type II branching in triantennary N-gly-
cans. This discovery signifies that rational glycoengineer-
ing along the given lines is an attractive perspective to
optimize pharmacokinetic behavior of glycosylated phar-
maproteins. Of general importance for the concept of the
sugar code, the presented results teach the fundamental
lesson that N-glycan core substitutions convey distinct
characteristics to the concerned oligosaccharide relevant
for cis and trans biorecognition processes. These modi-
fications are thus molecular switches.
Keywords: agglutinin; drug targeting; glycoprotein;
lectin; neoglycoprotein; tumor imaging.
Introduction
Posttranslational modifications are an efficient and far-
reaching means to extend protein functionality profound-
ly. Looking at the rather small covalent modifications by
phosphorylation, acetylation or methylation, their impact
on protein activity, the generation of modified surface
epitopes sensed by distinct receptors which can sub-
sequently initiate downstream signaling and their index-
ing potential underlying epigenetic processes explain
why they are referred to as biological code systems
(Barbieri, 2008; Sims and Reinberg, 2008). Furthermore
in this respect, a distinct class of structurally much more
variegated additions in protein conjugates can even
‘impart a discrete recognitional role to the protein’,
because their building blocks are ‘ideal for generating
compact units with explicit informational properties’,
i.e., oligosaccharides (Winterburn and Phelps, 1972).
Because introduction of these complex glycans matches
the level of occurrence of protein phosphorylation and
oligosaccharides have an unsurpassed capacity for infor-
mation coding, these attributes of protein glycosylation
inspired the concept of the sugar code (Gabius, 2009). It
is ‘the most complex known chemical code in a short
sequence among all biological oligomers’ (Laine, 1997)
and by definition predictive of a host of downstream
events. They can be triggered by two principal mecha-
nisms: (i) altering protein folding and routing as well as
reactivity with ligands or other proteins, and (ii) acting as
biochemical signals decoded by lectins (Sharon and Lis,
1997; Reuter and Gabius, 1999; Solı´s et al., 2001; Gabius
et al., 2004; Honke and Taniguchi, 2009). Hereby, the fun-
damental functional potential of glycans is broadly real-
ized, giving ample reason for the interest to delineate
detailed structure-function relationships.
With regard to N-glycans, distinct substitutions in the
common core region are known from structural glyco-
mics (Wilson et al., 2009; Zuber and Roth, 2009). Their
presence can definitely not be dismissed as a random
event. As an initial measure to appraise the role of
modifications it can give the synthetic route to mature N-
glycans a clear direction (Brockhausen and Schachter,
1997). As an illuminating example for this role, the relative
timing of adding a bisecting N-acetylglucosaminyl
(GlcNAc) moiety by N-acetylglucosaminyltransferase-III
(GnT-III) commits N-glycan synthesis either to hybrid or
to complex-type N-glycans (Brockhausen and Schachter,
1997). Also, its insertion precludes forming branches by
GnT-IV/V and the a1,6-fucosylation of the core by fuco-
syltransferase-VIII (FucT-VIII), the latter substitution mode
establishing a second common modification of the core
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Figure 1 Structure of a biantennary complex-type N-glycan (nonasaccharide: Bi9) with the two common core substitutions, i.e.,
introduction of core-fucose (F) and bisecting GlcNAc (B) moieties, to yield the two monosubstituted decasaccharides BiB10 and
BiF10 and the disubstituted undecasaccharide BiBF11.
N-glycan and a means to inhibit de-N-glycosylation by
N-glycanase (Suzuki et al., 1997; Ma et al., 2006; Wilson
et al., 2009; Zuber and Roth, 2009). Figure 1 shows the
precise positions and linkage modes of both mentioned
types of covalent addition to the N-glycan core. Having
looked at synthesis and cleavage, it becomes an obvious
question as to whether the introduction of these two core
modifications will affect the properties of the mature
N-glycan. That being said, it is intuitively attractive to
propose that they might act as molecular switches for
the conformational behavior of glycans. Explicitly, the
topology of individual glycan antennae can then be
altered, and can even connote to modulate lectin binding
at branch ends. In this case, core substitutions would
qualify as switches with effects in the immediate vicinity,
making their presence felt at distant sites.
In what follows we address this issue by reviewing
recent results using molecular modeling in silico and cell-
binding assays in vitro as well as monitoring biodistri-
bution with neoglycoproteins in vivo. These laboratory
tools present synthetic N-glycans on a particular protein
backbone after chemical conjugation (Gabius, 2001). In
contrast to natural glycoproteins their carbohydrate part
is free of microheterogeneity so that neoglycoproteins
enable clear-cut delineation of structure-function corre-
lations. The collective evidence establishes a valuable
guideline how the natural core substitutions will impinge
on serum survival of pharmaglycoproteins. They are
amenable to rational manipulation of their carbohydrate
part to avoid rapid clearance. The first step to be taken
will lead readers from the structure of the N-glycan in two
dimensions, as given in Figure 1, to the third dimension
of the sugar code.
The third dimension of the sugar code
A hallmark of oligosaccharides, setting them apart from
the highly flexible peptides, is their limited conformational
space (von der Lieth et al., 1998). The bulky rings linked
by glycosidic bonds can only be accommodated in few
positions without clashes. Drawing on the famous lock-
and-key principle by E. Fischer (1894), ‘the carbohydrate
moves in solution through a bunch of shapes each of
which can be selected by a receptor’, thus establishing
‘a bunch of keys’ (Hardy, 1997). Peptides, in contrast,
acquire such conformational preferences by disulfide
bonding, in the structural context of a protein or in the
presence of a ligand, as shown recently for three 15mer
peptides binding to ganglioside GM1 (Siebert et al.,
2006a). That the carbohydrate conformers reside in dis-
tinct low-energy positions constitutes the third dimension
of the sugar code, the step from a code word written in
a sequence to a shape destined for thermodynamically
favorable receptor binding (Gabius et al., 2004). The pre-
dicted conformer selection upon binding has been widely
documented, e.g., in the case of the pentasaccharide of
ganglioside GM1 and differential shape recognition of the
same sequence by bacterial/human lectins (Siebert et al.,
2003). Each energetically privileged conformer (‘key’) can
thus have its distinct bioactivity profile, fitting into a
distinct ‘lock’.
The principle of limited flexibility does not only hold
true for the glycan part directly in contact with receptors.
It concerns every glycosidic linkage, and long-range
effects are possible in complex glycans. Since confor-
mational preferences in oligovalent N-glycans may there-
fore have a bearing on the local density of branch-end
Bereitgestellt von | Universitaetsbibliothek der LMU Muenchen
Angemeldet | 129.187.254.47
Heruntergeladen am | 14.11.13 15:15
Core substitutions modulate shape and lectin affinity 559
Article in press - uncorrected proof
Figure 2 Assignment of symbols to all glycosidic torsion angles for the undecasaccharide BiBF11 using coding in gray tones for
clarity (center part).
The conformational flexibility is figured by respective maps in terms of accessible conformational space showing superposed results
of three independent molecular dynamics simulations at 400 K for a period of 1 ns (peripheral part).
determinants, this factor is supposed to be relevant for
modulating avidity of interaction of glycan determinants
in natural glycoproteins with lectins. Respective data on
importance of branching and local density have already
been presented, e.g., in the case of adhesion/growth-
regulatory mammalian galectins, and are being exploited
in glycocluster design (Andre´ et al., 1999, 2008; Wu et
al., 2004, 2006; Dam et al., 2005; Chabre and Roy, 2009).
Having herewith identified shape and local density of
branch-end epitopes as salient features in glycan func-
tionality, it is tempting to view core substitutions as
molecular switches in this context, and for good reason.
Of note, the acquisition of resistance to the plant toxin
ricin, specific exclusively for branch-end b-galactosides,
by the LEC10 mutant Chinese hamster ovary (CHO) cells
was attributed to induction of GnT-III activity (Campbell
and Stanley, 1984; Stanley et al., 1991). The core disub-
stitution resulting from adding the bisecting GlcNAc
residue to core-fucosylated N-glycans of these cells
thus appears to be a negative regulator of lectin binding,
although ricin will not directly interact with the core sec-
tion. Computational chemistry is a means to contribute
to detect the implied occurrence of spatial long-range
effects.
Will core substitutions shift conformational equilibria
in N-glycans?
The hypothesis of switch-like effects on conformational
behavior was tested systematically on complex-type
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Figure 3 Conformational fingerprint with illustration of the favored spatial constellation of the four N-glycans.
Illustration of energetically privileged conformations from the most densely populated conformational cluster of the N-glycans Bi9
(without core substitution), BiB10/BiF10 (with either bisecting GlcNAc or core-fucose units), and the disubstituted BiBF11 (for struc-
tures, please see Figure 1), revealing backfolding of the a1,3-arm (Bi9, BiF10) and the a1,6-arm (Bi9, BiF10 and BiBF11) (left panel).
Information given in the sets of maps describing intramolecular flexibility at each glycosidic linkage (Figure 2) is transformed into
spherical coordinates yielding fingerprint-like representations (right panel). The set of circles in each diagram defines values of torsion
angles, starting at -1808 for the smallest innermost circle and finally reaching q1808 at the outer boundary. The stepwise change in
angle from circle to circle is 608. In order to maintain cluster continuity a crossing of the line of the innermost circle is allowed to
depict values beyond -1808 in the center in the special case of C6 in the decasaccharide BiB10. Each radial line denotes a particular
glycosidic torsion angle, with total numbers of parameters ranging from 17 for the nonasaccharide Bi9 up to 22 for the undecasac-
charide BiBF11. For clarity and convenience, the coding in gray tones of Figure 2 is maintained.
biantennary glycans by performing molecular dynamics
simulations using TINKER software (Ponder, 2004) with
the MM3 parametrization (Stortz, 2005), as described
previously (Andre´ et al., 2007a). In detail, the conforma-
tional space accessed during the simulation periods was
compiled for each pair of dihedral glycosidic-linkage
angles wfor full assignment of symbols to angles in a bian-
tennary complex-type N-glycan (Bi9) with bisecting
GlcNAc (B) and core-fucose (F) moieties, establishing the
disubstituted BiBF11 N-glycan, see Figure 2x. As shown,
the complete consideration adds up to requirement of
analysis of 22 parameters. Their individual monitoring as
part of the glycan reveals evident clustering, indepen-
dently confirmed by 10 ns simulations at 300 K, when
inversions of the pyranose rings are precluded, and at
400 K with three different starting conformations (Andre´
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Figure 4 Cell binding of neoglycoproteins in relation to the core structure.
Comparison of fluorescent cell staining (left panel: percentage of positive cells; right panel: median fluorescence intensity) by labeled
neoglycoproteins presenting one of the four biantennary complex-type N-glycans Bi9, BiB10, BiF10, and BiBF11 (for nomenclature,
please see legend to Figure 1) for four human tumor lines: the B-lymphoblastoid line Croco II, the T-lymphoblastoid line CCRF-CEM,
and the two colon adenocarcinoma lines SW480/SW620. Standard deviations were generally less than 7.5%.
et al., 2007a). Because the resulting large number of
Ramachandran-like conformational maps at each glyco-
sidic angle will inevitably complicate to gain a clear grasp
on mutual dependence of conformational transitions in
a1,3/6-arms, we devised a single-plot fingerprint-like
presentation in polar coordinates for each regional por-
tion of the oligosaccharide. To track down an effect of
the core substitutions, we start the documentation with
the unmodified biantennary glycan (Bi9), then proceeding
to the two single-substituted N-glycans, i.e., with either
bisecting GlcNAc (BiB10) or core-fucose (BiF10) moie-
ties, respectively, and finally to the disubstituted N-gly-
can BiBF11 (Figure 3).
In Figure 3, a graphical illustration of the glycan in the
most densely populated conformational cluster is given
in each case (Figure 3, left), together with its conforma-
tional fingerprint (Figure 3, right). In this plot, each radial
line represents a particular torsion angle as defined in
Figure 2. The circles symbolize angle specification in
steps of 608, starting with -1808 at the inner circle. The
spatial positions of the most frequently encountered con-
formational group based on Boltzmann-energy-depend-
ent clustering among the complete array of topological
constellations sampled during the simulation periods are
depicted (Figure 3). On average, they are rather similar
for the two N-glycans Bi9 and BiF10, whereas BiB10
showed altered behavior at the first glycosidic linkages
of the a1,3/6-arms (see especially C6 in the right panel
of Figure 3). Importantly, presence of both substitutions
in the BiBF11 N-glycan led to a unique distribution of
predominantly accessed space. It is characterized by
preference to opposite orientations of the a1,6-antenna
relative to BiB10 and of the a1,3-antenna relative to Bi9/
BiF10 (Figure 3). In terms of local density of branch-end
epitopes, the two galactose residues are on average
5.9 A˚ apart in the Bi9/BiF10 N-glycans, 8.1 A˚ in the BiB10
compound and 22.1 A˚ in the BiBF11 glycan (Andre´ et al.,
2007a). Although flexibility in the a1,3/6-linkages extend-
ing from the trimannoside part of the core will certainly
still enable a dynamic equilibrium between extended and
backfolded orientations of the antennae, these calcula-
tions nonetheless reveal an indication for shifts in con-
formational equilibria. They depend on the presence of
these two core substitutions. Thus, they are modulators
for the shape of N-glycans, and these alterations engen-
der differences in relative positioning of branch-end
determinants, as shown in Figure 3 (left) and noted
above. As consequence, the reactivity of the glycans to
lectins may be subject to changes. If pure glycans were
available, this issue could be resolved. In that case, their
chemical attachment to a carrier protein will produce the
equivalent of natural glycoproteins, a neoglycoprotein,
with custom-made ligand part for lectin interaction
(Gabius et al., 1988, 1993; Danguy et al., 1994, 1995;
Lee and Lee, 1994; Legendre et al., 2004). Toward this
end, chemoenzymatic N-glycan synthesis and conjuga-
tion to serum albumin as standard carrier was performed
in all cases. Biopharmaceutical relevance was attained
by monitoring binding of the neoglycoproteins to tumor
cells in vitro and biodistribution in vivo. These experi-
ments explore the perspective for lectin-mediated drug
targeting and tumor imaging by rational glycoengineering
(Yamazaki et al., 2000).
Will core substitutions modulate cell binding?
Tumor cells of different histogenetic origin were tested
with the set of neoglycoproteins under identical experi-
mental conditions (Andre´ et al., 1997, 2004, 2007a;
Unverzagt et al., 2002). A dependence of carbohydrate-
mediated cell binding on the structural parameters of the
glycan chain is evident (Figure 4). Naturally, binding of
these glycans to cell surfaces can yet involve the branch-
end epitopes and also the core region, complicating the
interpretation. Both long-range effects and direct partic-
ipation of the added residue in binding and combinations
thereof are possible. Indeed, plant lectins, such as the
leguminous agglutinins LCA/PSA or the erythroaggluti-
nating phytohemagglutinin, respectively, serve as exam-
ples of lectins homing in on a certain type of core
substitution as part of their contact site (Goldstein and
Poretz, 1986). In order to relate spatial presentation of
galactose residues to cell binding with less ambiguity, we
next analyzed N-glycan functionality for hepatic uptake
in vivo, because ‘the rapidity of this transfer of asialo-
ceruloplasmin from plasma to liver has been shown to
be dependent upon the integrity of the exposed, terminal
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Figure 5 Comparison of N-glycan-type-dependent biodistri-
bution profiles of radioiodinated neoglycoproteins 1 h after their
intravenous injection into tumor-bearing mice.
Datasets for the four types of sialic acid-free N-glycans are
presented in the top panel, for the set of fully a2,3-sialylated
N-glycans in the middle panel, and for fully a2,6-sialylated N-
glycans in the bottom panel (for definition of glycan acronyms,
please see legend to Figure 1).
galactosyl residues’ (Morell et al., 1968). In fact, the so-
called asialoglycoprotein receptor of parenchymal liver
cells has become a role model for carbohydrate-specific
endocytic uptake (Rogers and Kornfeld, 1971; Lee and
Lee, 1994; Yamazaki et al., 2000; Park et al., 2005). Mon-
itoring biodistribution of neoglycoproteins, especially
blood and liver contents, is thus a sensitive diagnostic
tool to recognize an influence of N-glycan core substi-
tution on lectin-binding properties, with clinical perspec-
tives. Systematic experimental series with neoglyco-
proteins presenting the different N-glycans have thus
been carried out (Andre´ et al., 1997, 2004, 2007a; Unver-
zagt et al., 2002).
As shown in Figure 5, marked changes are detectable.
Most prominently, presence of both core substitutions
prolongs serum survival (Figure 5, top). The experiments
in tumor-bearing mice also made possible assessment of
the potential of the neoglycoproteins for imaging. Of note
in this respect, the introduction of a third branch by a
b1,2-addition of GlcNAc to the central mannose unit in
the core-fucosylated N-glycan (LEC14 modification) and
its galactosylation yielded a favorable tumor/blood ratio
(Andre´ et al., 2005). The same effect can alternatively be
reached by a2,3-sialylation in all four cases, excluding a
strong contribution of core substitutions as a major con-
tact point for the hepatic clearance route (Figure 5, mid-
dle). This type of addition of sialic acids to the glycan
antennae not only introduces a negative charge to the
oligosaccharide but also blocks lectin binding in this
system (Morell et al., 1968). However, what matters is
the mode of sialic acid addition, not its mere presence,
an instructive example of the versatility of glycans to
obtain non-synonymous signals from isomers (Reuter
and Gabius, 1996, 1999). In other words, sialylation in
a2,3- or a2,6-linkages facilitates to generate distinct
code words due to characteristic shape and flexibility
patterns (Siebert et al., 2006b). In our case, the positional
effect of sialylation is revealed by comparatively analyz-
ing the two sets of sialylated N-glycans. Historically, fol-
lowing its discovery the hepatic asialoglycoprotein
receptor has been shown to tolerate a2,6-sialylation as
branch-end modification, with species-dependent differ-
ences (Park and Baenziger, 2004; Park et al., 2005).
Marked differences in serum clearance and hepatic con-
tent were thus detected between N-glycans with a2,3-
or a2,6-sialylation, and an influence of core substitution
for a2,6-sialylated N-glycans was noted (Figure 5, middle
and bottom).
That structural parameters in the N-glycan affect lectin
reactivity is further underscored by similarly testing the
two common isomers of triantennary N-glycans. The two
branching modes are illustrated in Figure 6 as fully pro-
tected octasaccharides. They were the starting point for
processing by deprotection and the enzymatic chain
elongation (Andre´ et al., 2006). Reflecting the binding of
the b1,4-linked branch of the a1,3-arm to the minor
subunits of the hepatic C-type lectin and the rapid clear-
ance of the glycoprotein asialofetuin harboring type I
branching in the triantennary N-glycan chains (Lee et al.,
1983; Kojima et al., 1990; Rice et al., 1990), hepatic con-
tents were different between the isomers despite their
identical number of terminal galactose moieties (Figure
7). This case set another example for differences in bio-
activity by glycan tailoring. With potential for tumor deliv-
ery, uptake at this site was rather high with 4.18"0.5%
of the injected dose after 1 h for the a2,3-sialylated sec-
ond isoform (Andre´ et al., 2006). It exceeded that into
any organ. In conclusion, these results establish a guide-
line for rational glycoengineering, which can even prompt
to envision devising unnatural substitutions.
Concluding remarks
The impact of posttranslational modifications, such as
methylation or phosphorylation, on protein functionality
is well documented and widely appreciated. The growing
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Figure 6 Structures of the two fully protected, chemically synthesized octasaccharides.
Indicated are the two branching modes of triantennary complex-type N-glycans with type I branching composed of b1,2/b1,4-
antennae in the a1,3-arm (right) and type II branching with b1,2/b1,6-antennae in the a1,6-arm (left).
Figure 7 Comparison of N-glycan-type-dependent biodistri-
bution profiles of radioiodinated neoglycoproteins 1 h after their
intravenous injection into tumor-bearing mice.
Data are given for the sialic acid-free undecasaccharides with
type I/II branching TriI11/TriII11 (for structures of the two forms
differing in branching mode, see Figure 6), the fully a2,3-sialy-
lated tetradecasaccharides TriI1423/TriII1423, and the fully a2,6-
sialylated tetradecasaccharides TriI1426/TriII1426.
awareness of the exceptional talents of glycans in infor-
mation coding is the driving force to keep the body of
evidence for the assumed ‘discrete recognitional role’
(Winterburn and Phelps, 1972) of the glycan part of cel-
lular glycoconjugates dynamically growing. This concept
for a sugar code leads to the notion that substitutions in
glycan chains alter the nature of the conveyed signal in
functional terms. On the contrary, a provocative view
would attribute their occurrence to random events. Here,
we focused on two common core substitutions of N-gly-
cans, addressing the issues whether their presence can
modulate conformational and lectin-binding properties.
The results presented herein reveal the nature of core-
fucose and bisecting GlcNAc units as molecular switches
altering the accessed conformational space of the N-gly-
can by long-range effects. These changes can help
rationalize the measured impact of presence of substi-
tution on glycoproteins, such as growth factor receptors
when harboring core fucosylation (Wang et al., 2006;
Matsumoto et al., 2008; Honke and Taniguchi, 2009), and
on the lectin-binding properties of glycans. The present-
ed biodistribution data, also covering isomers of trian-
tennary N-glycans, provide a guideline for rational
glycoengineering of glycosylated pharmaproteins. Owing
to the potency of tissue lectins as elicitors of signaling in
concert with particular glycoprotein targets, such as the
a5b1-integrin or CD7 or as glycoprotein-specific transport
vehicles (Rappl et al., 2002; Villalobo et al., 2006; Andre´
et al., 2007b; Morelle et al., 2009), even a low overall
frequency of physiological substitution hitting these
functionally important sites will be effective. Structural
changes mapped by glycophenotyping, e.g., by glyco-
proteomics as a current approach in the quest to define
new cancer biomarkers, can thus hereby reach a func-
tional meaning. Finally, the unraveled activity of these N-
glycan core substitutions can be emblematic for other
types of glycan substitutions, e.g., when adorning N-gly-
can cores with a1,3-linked fucose or b1,2-linked xylose
units in plants and insects or with further GlcNAc moie-
ties in CHO glycosylation mutants or when leading to the
different cores of mucin-type O-glycans and branching
in O-mannosylated glycans (Patnaik and Stanley, 2006;
Patsos and Corfield, 2009; Wilson et al., 2009).
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